hydroxychloroquine has been researched along with Chronic Pain in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Khaddour, K | 1 |
Sikora, A | 1 |
Tahir, N | 1 |
Nepomuceno, D | 1 |
Huang, T | 1 |
Zschiebsch, K | 1 |
Fischer, C | 1 |
Wilken-Schmitz, A | 1 |
Geisslinger, G | 1 |
Channon, K | 1 |
Watschinger, K | 1 |
Tegeder, I | 1 |
2 other studies available for hydroxychloroquine and Chronic Pain
Article | Year |
---|---|
Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic.
Topics: Antibodies, Monoclonal, Humanized; Azithromycin; Betacoronavirus; Ceftriaxone; Chicago; Chronic Pain | 2020 |
Mast cell tetrahydrobiopterin contributes to itch in mice.
Topics: Animals; Biopterins; Calcium; Cell Degranulation; Chronic Pain; Female; Gene Expression; GTP Cyclohy | 2019 |